Medications for Endometrial Carcinoma

4 results

  • imfinzi - durvalumab injection, solution

    (Durvalumab)
    Astrazeneca Pharmaceuticals Lp
    Imfinzi is a PD-L1 antibody indicated for adults with NSCLC (resectable, unresectable Stage III, or metastatic), limited- and extensive-stage SCLC, biliary tract cancer, unresectable hepatocellular carcinoma, dMMR endometrial cancer, muscle-invasive bladder cancer, and resectable gastric/GEJ adenocarcinoma. Administered as monotherapy or with chemotherapy.
    Medication Details
    Drug Interactions

  • jemperli - dostarlimab injection

    (Dostarlimab)
    Glaxosmithkline Llc
    Jemperli treats adults with primary advanced or recurrent endometrial cancer (combined with carboplatin/paclitaxel or as monotherapy for dMMR tumors), and dMMR recurrent or advanced solid tumors that progressed on prior treatment with no satisfactory alternative options.
    Medication Details
    Drug Interactions

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions

  • lenvima - lenvatinib capsule

    (Lenvatinib)
    Eisai Inc.
    LENVIMA treats adults with radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (with pembrolizumab or everolimus), unresectable hepatocellular carcinoma, and advanced endometrial carcinoma (with pembrolizumab) in pMMR or non-MSI-H patients who progressed after prior therapy.
    Medication Details
    Drug Interactions